| |
| Activity Release and Expiration Dates |
Course Number: CME 07WSAUA
Release date: February 6th, 2008 valid through February 6th, 2009. |
| |
| Target Audience |
Urologists and urology residents, primary care physicians and healthcare professionals needing access to information targeted on the latest advances, current approaches to the diagnosis and treatment of urologic diseases. |
| |
| Educational Objectives |
Upon completion of the Western Section American Urological Association’s 83rd Annual Meeting webcasts, the participant will be able to:
- Discuss the latest advances and current approaches to the diagnosis and treatment of a large spectrum of urologic diseases;
- Utilize the basic scientific principles and the basic science knowledge to thoroughly understand the rationale behind current urologic diagnosis and treatment;
- Maintain, develop or increase knowledge, skills and professional relationships that a physician uses to provide and improve patient care.
|
| |
Implementation and Method of Physician Participation in the Learning Process |
| There is no charge to view the educational material. |
| |
Follow these steps to complete the webcasts:
- View the video and slide presentation.
- Take the online test and complete the online evaluation.
- Review your test answers before submitting.
- Receive a passing score of 70% or higher.
- Discuss the information covered with your staff or colleagues.
American Disabilities Act Statement: For accommodations on the basis of disability, call: 34 93 459 2220.
The American Urological Association is an Equal Opportunity Institution. |
| |
| Faculty Speaker Disclosure |
Listed below are the faculty who have disclosed (a) relationship (s) with industry: |
| |
| CME Presenter |
| Author |
Disclosure |
| Hamilton, Blake |
NextMed, Inc., Advisor |
| Kane, Christopher |
Intuitive Surgical, Consultant; Boerhgeraugteheis Consultant |
| Presti, Jr., Joseph |
Threshold, Consultant; Novocea, Consultant |
| Septer, Allen D. |
Pfizer, Consultant; Lilly, Consultant; Auxilium, Consultant; Solvay, Consultant |
| Weiss, Jeffrey P. |
Ferring, Consultant |
| |
|
| Program Committee |
| Annette Stork |
TTMed International Product Manager, Prous Science |
| Nancy Hagman |
TTMed International Product Manager, Prous Science |
| Barbara L. Jones |
Medical Writer |
|
| |
| Accreditation Statement |
| The American Urological Association Education and Research, Inc.(AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians. The AUAER. takes responsibility for the content, quality and scientific integrity of this CME activity. |
| |
| Credit Designation |
The American Urological Association designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| |
| AUA Disclosure Policy |
As a provider accredited by the ACCME, AUAER must insure balance, independence, objectivity and scientific rigor in all its activities.
All faculty participating in an educational activity provided by the AUAER, are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUAER must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty's relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses are discussed, these are also indicated. |
| |
| Unlabeled/Unapproved Uses of Drugs or Devices Notice |
It is the policy of the AUAER to require the disclosure of all references to unlabeled or unapproved uses of drugs or devises prior to the presentation of educational content.
The audience is advised that this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. |
| |
| Disclaimer |
| The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER. |
| |
| Evidence-based Content |
| As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous and free of commercial bias. |
